10-Q Filing

GLUCOSE HEALTH, INC. CIK: 1420108 Q3 2012

Filing Information

Form Type	10-Q
Accession Number	`0001471242-12-001449`
Period End Date	20120930
Filing Date	20121114
Fiscal Year	2012
Fiscal Period	Q3
XBRL Instance	bisu-20120930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 53 Income Statement 76 Cash Flow Statement 43

Balance Sheet 53 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	75.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	90.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	90.00M	shares	Point-in-time
Cash	`Cash`	$82.00	USD	Point-in-time
Cash	`Cash`	$277.00	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	74.33M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	65.44M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	74.33M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	65.44M	shares	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$27.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$27.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$27.28K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$27.08K	USD	Point-in-time
Intellectual Property	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$206.60K	USD	Point-in-time
Intellectual Property	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$206.60K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$233.68K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$233.88K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$151.59K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$296.43K	USD	Point-in-time
Liability for stock to be issued	`LiabilityForStockToBeIssued`	$225.00K	USD	Point-in-time
Liability for stock to be issued	`LiabilityForStockToBeIssued`	$41.50K	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	-	USD	Point-in-time
Short - term loans	`NotesPayableCurrent`	$19.67K	USD	Point-in-time
Short - term loans - related parties	`DueToRelatedPartiesCurrent`	$49.16K	USD	Point-in-time
Short - term loans - related parties	`DueToRelatedPartiesCurrent`	$1.58K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	$8.20K	USD	Point-in-time
Short - term loans - convertible	`ConvertibleNotesPayableCurrent`	$79.72K	USD	Point-in-time
Due to officer	`DueToOfficersOrStockholdersCurrent`	-	USD	Point-in-time
Due to officer	`DueToOfficersOrStockholdersCurrent`	$4.75K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$419.70K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$457.89K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$419.70K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$457.89K	USD	Point-in-time
Common stock, $0.001 par value, 90,000,000 shares authorized, 74,330,397 and 65,440,397 shares issued and outstanding as of September 30, 2012 and December 31, 2010, respectively	`CommonStockValue`	$65.44K	USD	Point-in-time
Common stock, $0.001 par value, 90,000,000 shares authorized, 74,330,397 and 65,440,397 shares issued and outstanding as of September 30, 2012 and December 31, 2010, respectively	`CommonStockValue`	$74.33K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$3.50M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$2.86M	USD	Point-in-time
Deferred Compensation	`DeferredCompensationLiabilityCurrent`	$-187.50K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.87M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.87M	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$169.57K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$657.32K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-69.22K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-75.81K	USD	Point-in-time
Total stockholders' deficiency	`StockholdersEquity`	$-186.02K	USD	Point-in-time
Total stockholders' deficiency	`StockholdersEquity`	$-224.01K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	`LiabilitiesAndStockholdersEquity`	$233.88K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	`LiabilitiesAndStockholdersEquity`	$233.68K	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`SalesRevenueGoodsNet`	-	USD	1 Quarter
REVENUE	`SalesRevenueGoodsNet`	-	USD	1 Quarter
REVENUE	`SalesRevenueGoodsNet`	-	USD	3 Qtrs
REVENUE	`SalesRevenueGoodsNet`	-	USD	3 Qtrs
Beginning inventory	`InventoryFinishedGoods`	$87.76K	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	$90.52K	USD	Point-in-time
Beginning inventory	`InventoryFinishedGoods`	$-83.27K	USD	Point-in-time
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	$-8.12K	USD	3 Qtrs
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	-	USD	3 Qtrs
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	$-8.12K	USD	1 Quarter
Purchases/Write-off of obsolete inventory	`PurchasesWriteoffOfObsoleteInventory`	-	USD	1 Quarter
Ending inventory	`InventoryFinishedGoods`	$87.76K	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	-	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	$90.52K	USD	Point-in-time
Ending inventory	`InventoryFinishedGoods`	$-83.27K	USD	Point-in-time
Total Cost of Revenues	`CostOfGoodsSold`	$-874.00	USD	1 Quarter
Total Cost of Revenues	`CostOfGoodsSold`	$-3.63K	USD	3 Qtrs
Total Cost of Revenues	`CostOfGoodsSold`	-	USD	3 Qtrs
Total Cost of Revenues	`CostOfGoodsSold`	-	USD	1 Quarter
GROSS PROFIT (LOSS)	`GrossProfit`	-	USD	1 Quarter
GROSS PROFIT (LOSS)	`GrossProfit`	$3.63K	USD	3 Qtrs
GROSS PROFIT (LOSS)	`GrossProfit`	-	USD	3 Qtrs
GROSS PROFIT (LOSS)	`GrossProfit`	$874.00	USD	1 Quarter
Professional fees and wages	`SalariesAndWages`	$707.23K	USD	3 Qtrs
Professional fees and wages	`SalariesAndWages`	$208.33K	USD	1 Quarter
Professional fees and wages	`SalariesAndWages`	$156.96K	USD	1 Quarter
Professional fees and wages	`SalariesAndWages`	$232.10K	USD	3 Qtrs
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	3 Qtrs
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	3 Qtrs
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	1 Quarter
Amortization expense and impairment	`AmortizationExpenseAndImpairment`	-	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.33K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$14.16K	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$632.00	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.12K	USD	3 Qtrs
Total Operating Expenses	`OperatingExpenses`	$721.39K	USD	3 Qtrs
Total Operating Expenses	`OperatingExpenses`	$237.22K	USD	3 Qtrs
Total Operating Expenses	`OperatingExpenses`	$208.97K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$161.29K	USD	1 Quarter
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-208.97K	USD	1 Quarter
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-237.22K	USD	3 Qtrs
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-717.76K	USD	3 Qtrs
NET LOSS BEFORE OTHER EXPENSE	`OperatingIncomeLoss`	$-160.42K	USD	1 Quarter
Interest expense	`InterestExpense`	$73.97K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.32K	USD	1 Quarter
Interest expense	`InterestExpense`	$238.03K	USD	3 Qtrs
Interest expense	`InterestExpense`	$11.86K	USD	3 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-11.86K	USD	3 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-238.03K	USD	3 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-1.32K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-73.97K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-729.61K	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$-282.94K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-161.74K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-475.25K	USD	3 Qtrs
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	69.40M	shares	3 Qtrs
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	73.77M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	32.55M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	26.29M	shares	3 Qtrs
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.00	USD	1 Quarter
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.03	USD	3 Qtrs
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
NET LOSS PER SHARE	`EarningsPerShareBasic`	$-0.01	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-729.61K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-282.94K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-161.74K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-475.25K	USD	3 Qtrs
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$5.32K	USD	3 Qtrs
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-6.65K	USD	1 Quarter
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-6.59K	USD	3 Qtrs
Currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$23.27K	USD	1 Quarter
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-289.59K	USD	1 Quarter
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-138.46K	USD	1 Quarter
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-481.84K	USD	3 Qtrs
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-724.29K	USD	3 Qtrs

Cash Flow Statement 43 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-729.61K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-282.94K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-161.74K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-475.25K	USD	3 Qtrs
Impairment expense	`AssetImpairmentCharges`	-	USD	3 Qtrs
Impairment expense	`AssetImpairmentCharges`	-	USD	3 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$607.82K	USD	3 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$169.00K	USD	3 Qtrs
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-235.54K	USD	3 Qtrs
Beneficial Conversion Feature of Notes Payable	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-73.18K	USD	1 Quarter
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$103.49K	USD	3 Qtrs
Increase (decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$4.03K	USD	3 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$408.57K	USD	3 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$711.31K	USD	3 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-66.68K	USD	3 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-18.30K	USD	3 Qtrs
Issuance of stock for cash	`ProceedsFromIssuanceOfCommonStock`	$11.48K	USD	3 Qtrs
Issuance of stock for cash	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	-	USD	3 Qtrs
Proceeds from short-term loans, net of repayments	`ProceedsFromRepaymentsOfShortTermDebt`	$9.95K	USD	3 Qtrs
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	-	USD	3 Qtrs
Proceeds from short-term loans - related party, net of repayments	`ShorttermLoansRelatedPartyNetOfRepayments`	-	USD	3 Qtrs
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	$-2.39K	USD	3 Qtrs
Proceeds from convertible notes payable, net of repayments	`ProceedsFromRepaymentsOfOtherDebt`	$61.60K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$19.04K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$61.60K	USD	3 Qtrs
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	$3.16K	USD	3 Qtrs
Effect of foreign currency	`EffectOfExchangeRateOnCashAndCashEquivalents`	$5.27K	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$195.00	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$3.90K	USD	3 Qtrs
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$82.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$33.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$277.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$3.93K	USD	Point-in-time
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$14.10K	USD	3 Qtrs
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$278.59K	USD	3 Qtrs
Conversion of notes payable and accrued interest to common stock	`DebtConversionConvertedInstrumentAmount1`	$10.00K	USD	2 Qtrs
Conversion of liability to common stock	`StockIssued1`	$142.43K	USD	3 Qtrs
Conversion of liability to common stock	`StockIssued1`	$41.50K	USD	3 Qtrs
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	-	USD	3 Qtrs
Acquisition of intellectual property of Type2 Defense for common shares	`StockIssued2`	$200.00K	USD	3 Qtrs
Conversion of accounts payable and notes payable to equity (Note 7)	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$217.81K	USD	3 Qtrs
Conversion of accounts payable and notes payable to equity (Note 7)	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	-	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.